CN1778960A - Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit - Google Patents
Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit Download PDFInfo
- Publication number
- CN1778960A CN1778960A CN 200410065553 CN200410065553A CN1778960A CN 1778960 A CN1778960 A CN 1778960A CN 200410065553 CN200410065553 CN 200410065553 CN 200410065553 A CN200410065553 A CN 200410065553A CN 1778960 A CN1778960 A CN 1778960A
- Authority
- CN
- China
- Prior art keywords
- magnesium ion
- reagent
- thio
- glycerol
- damping fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 82
- 238000000034 method Methods 0.000 title claims abstract description 59
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 229910001425 magnesium ion Inorganic materials 0.000 title claims abstract description 51
- 102000004190 Enzymes Human genes 0.000 title abstract description 12
- 108090000790 Enzymes Proteins 0.000 title abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000012360 testing method Methods 0.000 claims abstract description 22
- 239000005515 coenzyme Substances 0.000 claims abstract description 19
- 102000057621 Glycerol kinases Human genes 0.000 claims abstract description 16
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims abstract description 13
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000013016 damping Methods 0.000 claims description 22
- 239000012530 fluid Substances 0.000 claims description 22
- 238000009007 Diagnostic Kit Methods 0.000 claims description 20
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 108700016170 Glycerol kinases Proteins 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 claims description 12
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 230000001186 cumulative effect Effects 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 238000007824 enzymatic assay Methods 0.000 claims description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 7
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 229960004418 trolamine Drugs 0.000 claims description 6
- CXONXVMMINSQBV-NNYOXOHSSA-N (2r,3r,4s,5r)-5-[[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-carbamothioylpyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate Chemical compound NC(=S)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)[O-])=C1 CXONXVMMINSQBV-NNYOXOHSSA-N 0.000 claims description 4
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims description 4
- 150000002460 imidazoles Chemical class 0.000 claims description 4
- 229950006238 nadide Drugs 0.000 claims description 4
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 108010008488 Glycylglycine Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 claims description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229910021538 borax Inorganic materials 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004327 boric acid Substances 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 229940099352 cholate Drugs 0.000 claims description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 claims description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 claims description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 claims description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229960001031 glucose Drugs 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-M glutaminate Chemical compound [O-]C(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-M 0.000 claims description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 2
- 235000003969 glutathione Nutrition 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 229940043257 glycylglycine Drugs 0.000 claims description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 229950001574 riboflavin phosphate Drugs 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 239000004328 sodium tetraborate Substances 0.000 claims description 2
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 2
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 20
- 239000000463 material Substances 0.000 abstract description 6
- 101710088194 Dehydrogenase Proteins 0.000 abstract description 2
- 238000005859 coupling reaction Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 101710163410 Probable glycerol kinase Proteins 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000009189 diving Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 6
- 238000003321 atomic absorption spectrophotometry Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 3
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 3
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- VBRNLOQCBCPPHL-UHFFFAOYSA-N calmagite Chemical compound CC1=CC=C(O)C(N=NC=2C3=CC=CC=C3C(=CC=2O)S(O)(=O)=O)=C1 VBRNLOQCBCPPHL-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000009666 routine test Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- VXEQGQXRKQSAMW-UHFFFAOYSA-N 2-amino-2-methylpropan-1-ol Chemical compound CC(C)(N)CO.CC(C)(N)CO VXEQGQXRKQSAMW-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZQYUHRVUJCLGRX-UHFFFAOYSA-N NCC(=O)NCC(O)=O.NCC(=O)NCC(O)=O Chemical compound NCC(=O)NCC(O)=O.NCC(=O)NCC(O)=O ZQYUHRVUJCLGRX-UHFFFAOYSA-N 0.000 description 1
- 102000009569 Phosphoglucomutase Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 108091000115 phosphomannomutase Proteins 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- IBUIVNCCBFLEJL-UHFFFAOYSA-M sodium;phosphoric acid;chloride Chemical compound [Na+].[Cl-].OP(O)(O)=O IBUIVNCCBFLEJL-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- DIZZDZCUMBBRSG-UHFFFAOYSA-J tetrasodium;2-[[5-[3-[3-[[bis(carboxylatomethyl)amino]methyl]-4-hydroxy-2-methyl-5-propan-2-ylphenyl]-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-2-hydroxy-6-methyl-3-propan-2-ylphenyl]methyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(CN(CC([O-])=O)CC([O-])=O)C(O)=C(C(C)C)C=2)C)=C1C DIZZDZCUMBBRSG-UHFFFAOYSA-J 0.000 description 1
- CZIRZNRQHFVCDZ-UHFFFAOYSA-L titan yellow Chemical compound [Na+].[Na+].C1=C(C)C(S([O-])(=O)=O)=C2SC(C3=CC=C(C=C3)/N=N/NC3=CC=C(C=C3)C3=NC4=CC=C(C(=C4S3)S([O-])(=O)=O)C)=NC2=C1 CZIRZNRQHFVCDZ-UHFFFAOYSA-L 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention is about the enzyme method of measuring magnesium ion and its diagnosis reagent box. Making use of the peculiarity that magnesium ion in the sample of plasma or serum and so on can activate the activation of glycerokinase, and producing glycerol-3-phosphoryl by reacting glycerol under the existence of adenosine triphosphate, and then causing coupled reaction with glycerol-3-phosphoryl dehydrogenase and transferring oxidized coenzyme to reduced coenzyme. Testing the descending range of dominant wave-length340nm absorbance and finally measuring the content of magnesium ion in the sample. This method has high specificity and would not be contaminated by material of internal and exogenous sources, and the result is precise and accurate. Diving the diagnosis reagent box into double-dose or three-dose can reduces the cross interaction of each element, keeps the stability of the reagent and deposits chronically. Using this method can realize the fast testing in common ultraviolet/ visible light analyzer or semiautomatic/automatic analyzer and doesn't require special or additional apparatus, so the cost is low. Thus, this method can be easily promoted and applied in the whole industry.
Description
Technical field
The present invention relates to the method for magnesium ion content in the samples such as enzymatic assays blood plasma, serum, and use the formulated magnesium ion diagnostic kit of this method, belong to medical test determination techniques field.
Background technology
The means of medically measuring magnesium ion content (abbreviation magnesium determination) in the samples such as blood plasma, serum at present are many, summarize to get up to have: colorimetry, fluorescent method, ion chromatography, ion specific electrode method (ISE), enzyme process, atomic absorption spectrophotometry (AAS), isotopic dilution mass spectrometry (ID-MS) etc.Wherein conclusive method is ID-MS, secondly is AAS, though these two kinds of method results are accurate, equipment complexity, expense costliness are not suitable for Routine Test Lab and analysis automatically.
Colorimetry is most widely used method, comprising: methyl thymol blue method (MTB), titan yellow method, OCPC method (OCPC), calmagite method (Calmagite) and 2-(8 '-hydroxyquinoline-5 '-sulfonic acid-7 '-azo)-variable color acid system (8Q5SAC) of reporting recently.Colorimetry is easy and simple to handle, expense is low, is fit to Routine Test Lab and uses, but have reagent blank absorbancy height, be subject to bilirubin and other positively charged ion disturbs, reagent stability is poor, and contain in the reagent and be corrosive or shortcoming such as toxic component.Ion specific electrode method (ISE) can be measured magnesium ion activity in the physiological solution, adopts neutral carrier (ETH7025) liquid film ion selective electrode, and the accuracy of mensuration is higher, but still exists the calcium in the physiological range to disturb Ca
2+Maximum interference reaches 10%.Ion chromatography needed sample is carried out pre-treatment before measuring, and comprised acidifying dilution and filtration.This method of uses such as Thienpont is analyzed with the definite value serum of atomic absorption spectrophotometry five kinds " international standard and technology meetings ", average deviation is 0.35% only as a result, thinks that ion chromatography can be used as the valuable reference method of measuring the magnesium elements total amount.
Magnesium ion (mainly is Mg in the samples such as enzymatic assays blood plasma, serum
2+) research very active in recent years, obtained bigger progress.Be applied to Mg at present
2+The Enzymology method of measuring has: 1. glycerol kinase and glucose-6-phosphate dehydrogenase coupling method; 2. glycerol kinase, GPO and superoxide enzyme coupling method; 3. glucokinase and glucose-6-phosphate dehydrogenase coupling method; 4. enzyme joins chemoluminescence method; 5. phosphoglucomutase and glucose-6-phosphate dehydrogenase coupling method; 6. isocitric enzyme method; 7. pyruvate kinase and lactic dehydrogenase enzyme coupling method.
On the whole, employing enzyme process detection magnesium ion result is accurate, interference is little, be suitable for automated analysis.But, use different detection reagent and test route, the sensitivity of detection, the accuracy of detected result have very big difference, directly have influence on the use and the popularization of this method, and this is the people reason place constantly studying in the field, develop and innovate just.Because extraordinary application prospect arranged, the research that enzyme process is detected magnesium ion has become the focus in this field.
Summary of the invention
The objective of the invention is: a kind of method of enzymatic assays magnesium ion content is provided, and uses the formulated magnesium ion diagnostic kit of this method.Adopt the reagent in this test kit, can utilize ultraviolet analyser or semi-automatic/automatic clinical chemistry analyzer that the content of magnesium ion in the samples such as blood plasma, serum is carried out fast, accurately measures, so that promote the use of method and corresponding diagnostic kit that enzyme process detects magnesium ion, make this field in detection means obtain further abundant and develop.
For realizing purpose of the present invention, a kind of method of enzymatic assays magnesium ion content, adopt following steps to carry out:
At first,, make it to take place following reaction with needs such as blood plasma, serum sample of measuring and the reagent mixing that contains glycerine, adenosine triphosphate, glycerol kinase, glycerol-3-phosphate dehydrogenase and reduced coenzyme,
Then, reaction mixture is placed under ultraviolet analyser or the semi-automatic/automatic clinical chemistry analyzer, detect the fall of the absorbancy of predominant wavelength 340nm, and then calculate the content of magnesium ion in the sample.
In the mensuration process, the usage ratio of sample and reagent by volume was controlled at 1: 10～1: 500, and temperature of reaction is controlled at 20 ℃～50 ℃, and the reaction times was controlled at 2～30 minutes, set commplementary wave length during detection more than 405nm.
The magnesium ion diagnostic kit of realizing the inventive method can be single agent, is grouped into by following one-tenth:
Damping fluid 40～200mmol/l,
Glycerine 1～40mmol/l,
Adenosine triphosphate 0.2～20mmol/l,
Reduced coenzyme 0.2～0.3mmol/l,
Glycerol kinase 1000～50000U/l,
Glycerol-3-phosphate dehydrogenase 1000～50000U/l,
Stablizer/reagent cumulative volume 10～80%.
Also the various compositions in above single agent can be carried out formulated in combination and become two agent, be beneficial to eliminate the pollution of inside and outside source material, such as:
The prescription of two agent is not limited only in the above-mentioned table listed, wherein the composition of reagent I: glycerine, adenosine triphosphate, reduced coenzyme, glycerol-3-phosphate dehydrogenase etc. can be placed on reagent II; Glycerol kinase among the reagent II also can be put into reagent I, so can form multiple formulations, enumerates no longer one by one.
Reagent can also be made into following three reagent, not only more help eliminating the pollution of inside and outside source material, it is more stable to also help reagent:
Similar with two agent, three doses prescription also is not limited only to above-mentioned prescription, wherein the glycerine among the reagent I, adenosine triphosphate, reduced coenzyme etc. can be placed among reagent II or the reagent III, glycerol-3-phosphate dehydrogenase among the reagent II can be placed among reagent I or the reagent III, glycerol kinase among the reagent III also can be put among reagent I or the reagent II, so can form multiple formulations, enumerate no longer one by one.
In the middle of the composition of above-mentioned diagnostic kit, selecting the basic demand of damping fluid is that pH value is within 6.0～11.0 scopes, can be: " Tutofusin tris～hydrochloric acid (Tris-HCl) damping fluid ", " trolamine (Triethanolamine) damping fluid ", " 2-amino-2-methyl-1-propanol (2-Amino-2-methyl-1-propanol) damping fluid ", " imidazoles～hydrochloric acid (Imidazole-HCl) damping fluid ", " glycylglycine (Glycylglycine) damping fluid ", " citric acid～sodium citrate buffer solution ", " Veronal sodium～hydrochloride buffer ", " boric acid～borate buffer solution ", " glycine～sodium hydrate buffer solution ", " borax～sodium hydrate buffer solution ", at least a in " phosphoric acid (Phosphate) damping fluid " or " phosphoric acid salt (Phosphate-Sodium Chloride; PBS) damping fluid ", but range of choice be not subjected to these enumerate limit.
In addition, for reducing the cross influence between each reagent composition, the stability of maintenance reagent, so that standing storage, usually add stablizer in the middle of the reagent I/ reagent II of above single agent, two agent, three doses the reagent I/ reagent II/ reagent III, its consumption accounts for 10～80% (perhaps concentration is within 10～50mmol/l scopes) of place reagent cumulative volume.
Material with used as stabilizers can be: at least a in ethylene glycol, propylene glycol, glycerine, ammonium sulfate, thioglycol, adenosine diphosphate (ADP), bovine serum albumin, carbonate, cholate, dextran, ethylenediamine tetraacetic acid (EDTA), flavin adenine dinucleotide, vitamin B2 phosphate, glucose, glutaminate, reduced glutathion, lactose, N.F,USP MANNITOL, succinate or the sodium-chlor.
In the middle of the reagent composition of above-mentioned magnesium ion diagnostic kit, described oxidized coenzyme is---NAD (NAD
+), NADP+ (NADP
+), thio-NAD+ (thio-NAD
+) or thio-NADP+ (thio-NADP
+); Described reduced coenzyme is---nicotinamide adenine dinucleotide reduced (NADH), NADPH (NADPH), Thio-NADH (thio-NADH) or thio-NADPH (thio-NADPH).
No matter studies show that, take all factors into consideration from the accuracy of measurement result and economy two aspects of preparation cost, be single agent, two agent or three doses, and the magnesium ion diagnostic kit of following system component relation is comparatively desirable, also is preferred version of the present invention:
Damping fluid 80～120mmol/l,
Glycerine 10～20mmol/l,
Adenosine triphosphate 2～8mmol/l,
Reduced coenzyme 0.2～0.3mmol/l,
Glycerol kinase 10000～30000U/l,
Glycerol-3-phosphate dehydrogenase 10000～30000U/l,
Stablizer/reagent cumulative volume 10～50%.
The present invention uses magnesium ion and activates the active characteristics of glycerol kinase, the degree that the glycerol kinase activity intensifies is directly proportional with the content of magnesium ion in the samples such as blood plasma, serum, in the presence of adenosine triphosphate, generate glycerol-3-phosphate with glycerine reaction, the coupling glycerol-3-phosphate dehydrogenase is reacted into oxidized coenzyme with reduced coenzyme again.Because reduced coenzyme has very significantly absorption peak at 340nm, and the oxidized coenzyme of their correspondences does not have absorption peak at 340nm, the variation of the absorbancy that reaction is produced is directly proportional with the content of magnesium ion in the sample.Therefore, in Fixed Time Interval, measure the fall of predominant wavelength 340nm place absorbancy, just can reflect the content of magnesium ion in the sample well.
The outstanding substantive distinguishing features and the obvious improvement of technical solution of the present invention mainly shows:
(1) the present invention utilizes Enzymology method fully, and enzyme digestion reaction has the high characteristics of specificity, and by reduced coenzyme is reacted into oxidized coenzyme, quantitative response goes out the content of magnesium ion in the sample, and test result is accurate;
(2) composition of participation enzyme linked reaction all adds, and is not subjected to the pollution of inside and outside source material, test process tolerance range height;
(3) this method is easy, easy to operate, can obtain detected result fast, and the reaction be under buffer conditions, to carry out, do not pollute the environment;
(4) but this method just rapid detection on general ultraviolet/visible light analysis instrument or semi-automatic/automatic clinical chemistry analyzer does not need special or additional instruments, testing cost is cheap, is convenient to apply in the industry;
(5) use the reagent that measuring method provided by the invention can be made various ways such as liquid reagent, powdered reagent, dried reagent, be mainly used in the content of measuring magnesium ion in human body and other animal body, also can be, supplementary means such as concentrate and measure magnesium ion in other sample in conjunction with dilution;
(6) liquid magnesium ion diagnostic kit provided by the invention, good stability, the three-D space structure that is present in wherein each kind of enzyme is kept perfectly, and has guaranteed the application testing effect well.Make after two agent or three doses, can further reduce the cross influence between the various compositions, detected result is more credible, and reagent is more stable, can store for a long time.
Embodiment
Below in conjunction with specific embodiment technical solution of the present invention is described further.These examples only are some exemplary applications, can not be interpreted as a kind of restriction to claim protection domain of the present invention.
Embodiment one (single agent)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Glycylglycine damping fluid 80mmol/l,
Glycerine 10mmol/l,
Adenosine triphosphate 2mmol/l,
thio-NADH 0.2mmol/l，
Glycerol kinase 10000U/l,
Glycerol-3-phosphate dehydrogenase 10000U/l,
Ethylene glycol 50% (accounting for the reagent cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 37 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, the volume ratio of sample and reagent is 1: 25, the Direction of Reaction is negative reaction (absorbancy descends, down together).
Adding serum sample and the single agent that is made into, both detect, write down the decline situation of 340nm absorbancy at the inner mixing automatically of analyser.Detect altogether and read a little 31 times, approximately every 20 seconds record one secondary data, according to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment two (two agent)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Reagent I---
Imidazoles～hydrochloride buffer 100mmol/l,
Glycerine 15mmol/l,
Adenosine triphosphate 5mmol/l,
NADPH 0.25mmol/l，
Glycerol-3-phosphate dehydrogenase 20000U/l,
Ethylene glycol 50% (accounting for reagent I cumulative volume);
Reagent II---
Imidazoles～hydrochloride buffer 100mmol/l,
Glycerol kinase 20000U/l,
Ethylene glycol 50% (accounting for reagent II cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 30 ℃ of temperature, 15 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I and reagent II, reagent I is 4: 1 with the ratio of the consumption of reagent II, and the Direction of Reaction is negative reaction.
Adding serum sample and reagent I add reagent II after 5 minutes earlier, and the three detects, writes down the decline situation of 340nm absorbancy at the inner mixing automatically of analyser.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment three (three doses)
Prepare magnesium ion diagnostic kit in the serum by following composition and consumption:
Reagent I---
Trolamine damping fluid 120mmol/l,
Glycerine 20mmol/l,
Adenosine triphosphate 8mmol/l,
thio-NADPH 0.3mmol/l，
Propylene glycol 20mmol/l;
Reagent II---
Trolamine damping fluid 120mmol/l,
Glycerol-3-phosphate dehydrogenase 30000U/l,
Propylene glycol 50% (accounting for reagent II cumulative volume);
Reagent III---
Trolamine damping fluid 120mmol/l,
Glycerol kinase 30000U/l,
Ethylene glycol 50% (accounting for reagent III cumulative volume).
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 25 ℃ of temperature, 20 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I, reagent II and reagent III, the consumption of reagent I, reagent II and reagent III is 8: 1: 1, and the Direction of Reaction is negative reaction.
Adding serum sample and reagent I, reagent II add reagent III after 5 minutes earlier, and they detect, write down the decline situation of 340nm absorbancy at the inner mixing automatically of analyser.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
Embodiment four (two agent preference)
Prepare the serium inorganic phosphorus diagnostic kit by following composition and consumption:
Reagent I---
Tris-HCl damping fluid 100mmol/l,
Glycerine 10mmol/l,
Adenosine triphosphate 3mmol/l,
NADH 0.25mmol/l，
Ammonium sulfate 20mmol/l;
Reagent II---
Tris-HCl damping fluid 100mmol/l,
Glycerol kinase 16000U/l,
Glycerol-3-phosphate dehydrogenase 16000U/l,
Ammonium sulfate 20mmol/l.
Go up to set at automatic clinical chemistry analyzer (Hitachi-7080): 37 ℃ of temperature, 10 minutes reaction times, test predominant wavelength 340nm, more than the test commplementary wave length 405nm, sample is 1: 25 with the ratio of the cumulative volume of reagent I and reagent II, reagent I is 4: 1 with the ratio of the consumption of reagent II, and the Direction of Reaction is negative reaction.
Add serum sample and reagent I earlier, add reagent II after 5 minutes, following principle reaction takes place at the inner mixing automatically of analyser in the three:
Detect, write down the decline situation of 340nm absorbancy.According to methods such as rate method, end-point methods, the contrast corresponding standard curve calculates the content of magnesium ion in the serum sample.Same batch sample is repeatedly repeated above process, test result good reproducibility, tolerance range height.
In a word, experimental results show that and adopt measuring method of the present invention, can pass through ultraviolet analyser or semi-automatic/automatic clinical chemistry analyzer device fully, determine the content of magnesium ion in the samples such as blood plasma, serum, measurement sensitivity height, tolerance range are good, are not subjected to the pollution of inside and outside source material.And, magnesium ion diagnostic kit provided by the invention, good stability still can accurately detect the magnesium ion content in all kinds sample after the long storage time.
Claims (9)
1. the method for an enzymatic assays magnesium ion content may further comprise the steps:
1. with testing sample and the reagent mixing that contains glycerine, adenosine triphosphate, glycerol kinase, glycerol-3-phosphate dehydrogenase and reduced coenzyme, make it to take place following reaction,
2. reaction mixture is placed under ultraviolet analyser or the semi-automatic/automatic clinical chemistry analyzer, detect the fall of the absorbancy of predominant wavelength 340nm, calculate the content of magnesium ion in the sample.
2. the method for enzymatic assays magnesium ion content according to claim 1 is characterized in that: the usage ratio of testing sample and reagent by volume was controlled at 1: 10～1: 500.
3. the method for enzymatic assays magnesium ion content according to claim 1 and 2 is characterized in that: temperature of reaction is controlled at 20 ℃～50 ℃, and the reaction times was controlled at 2～30 minutes, sets commplementary wave length during detection more than 405nm.
4. magnesium ion diagnostic kit, reagent is grouped into by following one-tenth in the box:
Damping fluid 40～200mmol/l,
Glycerine 1～40mmol/l,
Adenosine triphosphate 0.2～20mmol/l,
Reduced coenzyme 0.2～0.3mmol/l,
Glycerol kinase 1000～50000U/l,
Glycerol-3-phosphate dehydrogenase 1000～50000U/l,
Stablizer/reagent cumulative volume 10～80%.
5. magnesium ion diagnostic kit according to claim 4 is characterized in that: the PH scope of described damping fluid is 6.0～11.0.
6. magnesium ion diagnostic kit according to claim 5 is characterized in that: described damping fluid is " Tutofusin tris～hydrochloride buffer ", " trolamine damping fluid ", " 2-amino-2-methyl-1-propanol damping fluid ", " imidazoles～hydrochloride buffer ", " glycylglycine damping fluid ", " citric acid～sodium citrate buffer solution ", " Veronal sodium～hydrochloride buffer ", " boric acid～borate buffer solution ", " glycine～sodium hydrate buffer solution ", " borax～sodium hydrate buffer solution ", at least a in " phosphoric acid buffer " or " phosphate buffered saline buffer ".
7. magnesium ion diagnostic kit according to claim 4 is characterized in that: described stablizer is at least a in ethylene glycol, propylene glycol, glycerine, ammonium sulfate, thioglycol, adenosine diphosphate (ADP), bovine serum albumin, carbonate, cholate, dextran, ethylenediamine tetraacetic acid (EDTA), flavin adenine dinucleotide, vitamin B2 phosphate, glucose, glutaminate, reduced glutathion, lactose, N.F,USP MANNITOL, succinate or the sodium-chlor.
8. magnesium ion diagnostic kit according to claim 4 is characterized in that: described oxidized coenzyme is---NAD NAD
+, NADP+ NADP
+, thio-NAD+ thio-NAD
+Perhaps thio-NADP+ thio-NADP
+Described reduced coenzyme is---nicotinamide adenine dinucleotide reduced NADH, NADPH NADPH, Thio-NADH thio-NADH or thio-NADPH thio-NADPH.
9. any magnesium ion diagnostic kit in the claim 4～8 is characterized in that: described reagent is made into single agent, two agent or three doses.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410065553 CN1778960A (en) | 2004-11-23 | 2004-11-23 | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410065553 CN1778960A (en) | 2004-11-23 | 2004-11-23 | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1778960A true CN1778960A (en) | 2006-05-31 |
Family
ID=36769415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410065553 Pending CN1778960A (en) | 2004-11-23 | 2004-11-23 | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1778960A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104726536A (en) * | 2013-12-24 | 2015-06-24 | 上海复星医药（集团）股份有限公司 | Stable reagent for determining magnesium ions by enzyme process |
-
2004
- 2004-11-23 CN CN 200410065553 patent/CN1778960A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104726536A (en) * | 2013-12-24 | 2015-06-24 | 上海复星医药（集团）股份有限公司 | Stable reagent for determining magnesium ions by enzyme process |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1769481A (en) | Blood ammonia content determination method and blood ammonia diagnosis kit | |
| CN1778956A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778960A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1786692A (en) | Process for determining content of potassium ion by enzyme method and kit for diagnosing potassium ion thereof | |
| CN1778963A (en) | Determination of blood ammonia content and blood ammonia diagnostic reagent kit | |
| CN1778958A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778962A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778955A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit | |
| CN1778957A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778959A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778961A (en) | Determination of magnesium ion content from enzyme method and magnesium ion diagnostic reagent kit | |
| CN1778953A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit | |
| CN1786187A (en) | Enzymatic method for determining potassium ion content and potassium ion diagnosis kit | |
| CN1778954A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit | |
| CN1778943A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit | |
| CN1778941A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit | |
| CN1786694A (en) | Process for determining content of carbon dioxide and kit for diagnosing carbon dioxide therefor | |
| CN1786691A (en) | Process for determining contect of potassium ion by enzyme method and kit for diagnosing potassium ion thereof | |
| CN1779464A (en) | Determination of inorganic phosphorus and its diagnostic kit | |
| CN1789427A (en) | Monoamine oxidase activity determination method and monoamine oxidase diagnostic kit | |
| CN1786186A (en) | Enzymatic method for determining sodium ion content and sodium ion diagnosis kit | |
| CN1641041A (en) | Adenosin-deaminase diagnostic kit and adenosine deaminease activity determining method | |
| CN1302119C (en) | Method for measuring 5'-nucleotidase activity and diagnostic reagent kit of 5'-nucleotidase | |
| CN1789428A (en) | Monoamine oxidase activity determination method and monoamine oxidase diagnostic kit | |
| CN1778952A (en) | Determination of inorganic phosphorus and its diagnostic reagent kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |